Amylin's long-delayed diabetes drug gets US nod (Associated Press, 28 January 2012)
01 Feb 2012
The US Food and Drug Administration has approved the long-acting GLP-1 agonist Bydureon for the treatment of type 2 diabetes mellitus.
Full article